Case studies
We're proud to support our clients journey in building capabilities across their organizations, creating impact that extends beyond financial and operational success. Here’s a glimpse into that journey.
BiopharmaWe supported a company looking to embark on a transformative journey and build capabilities for biosimilars manufacturing. We conducted an evidence-based analysis of a potential project, focusing on the project's strategic importance, the gap in demand and availability, commercial market dynamics, necessary investment costs, project timelines, and skills requirements
January 2025Pre-feasibility study for a generic manufacture looking to establish biologics manufacturing capabilities
Biopharma
Venture CapitalWe worked with a new investment fund to create a strategy for a premier launch event. Aiming to prepare an exciting agenda, we conducted market research with investors, entrepreneurs, and academia to assess the attractiveness and feasibility of elevating emerging research areas during the event.
March, 2023Developing a strategy for a world-class launch of an investment fund for biotech innovations
BiopharmaA family-owned business turned to us to prepare their business model and product portfolio overview for negotiations with prospective buyers. A special focus was placed on reviewing the target’s relationships with API suppliers and capacity of its supply chain operations
August 2024Vendor Due Diligence of a manufacturing company of animal and human products and in-licensing business
A medical company in the in vitro diagnostics space was falling short of its supply chain and procurement functions. We worked across the organisation—strategy, R&D, and supply chain to drive operational improvements by building forecasting capabilities, adding agility, and optimising the quality and cost of consumables
December 2024How to expand the supply chain capacity and synchronise efforts of all stakeholders
Biopharma/ Private EquityThe private equity firm asked us to conduct market and commercial due diligence for a company with a portfolio of products and technologies for molecular diagnostic and recommended a range of upsides and high-priority opportunities for strategic fit and future growth
November 2022Commercial Due Diligence of immunoassay development and manufacturing provider and its target markets
Digital Health/ Private Equity
Biopharma / Private EquityWe performed an annual sustainability review of a laboratory service provider for food and pharmaceutical analysis to monitor the implementation of key ESG initiatives along the Sustainable Development Goals matrix and beyond
March, 2021Helping a diagnostic company to advance implementation in ESG commitments
BiopharmaA pharma company sought to develop a payer engagement strategy for late-stage assets targeting a rare liver disease. The company aimed to develop measures for interacting with payers and payer advisory stakeholders to advance the field before launch and formulate an engagement plan
ExploreEngaging payers in the rare disease space to prepare the market environment for the entry of a gene therapy
We explored diversification opportunities in education for alternative medicine in Germany by creating a perspective on the verticals of the market, including the projection of demand, reimbursement status, structure of healthcare providers and competition
April 2023Expanding the growth opportunities of an education platform into alternative medicine space in Germany
Biopharma / Private EquityThe private equity investor was considering entering investing in a pet supplies online retailer. We conducted a detailed analysis of the market, its price dynamics, growth outlook, and competitive environment, as well as evaluating the target’s business plan and the feasibility of achieving upsides across multiple product and service categories
January 2022Validating a potential investment in an online retailer of pet products in Europe
Biopharma / Private Equity
BiopharmaWe worked with senior pharma executives to ensure launch support of a drug in the immunology space. By creating an understanding of an asset’s clinical profile and competitive positioning, we refined strategic communication materials to demonstrate its value in the HTA assessment and the pricing and reimbursement process.
June, 2023Partnering with a major pharma to refine the market access strategy for a rare disease asset
Medical DevicesWe helped the UN lead agency identify and qualify manufacturers of medical products to meet the growing demand in procurement. We conducted market research to identify companies and performed operational, legal, and technical due diligence to evaluate companies' eligibility for supply arrangements.
ExploreA development partner requires due diligence on manufacturers of medical products
We helped a client in the private equity space to conduct market due diligence for a target in the diagnostic market with a portfolio of ingredients for diagnostic assay. We segmented the market by technology type, application and end-user and characterised the key trends that shape the dynamic of each segment.
January 2025